Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data-Reference-Cited by-同舟云学术

Comparative safety and benefit-risk profile of biologics and oral treatment for moderate-to-severe plaque psoriasis: A network meta-analysis of clinical trial data

Published:2021-09 Issue:3 Volume:85 Page:572-581
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Shear Neil H.,Betts Keith A.,Soliman Ahmed M.,Joshi Avani,Wang Yan,Zhao Jing,Gisondi Paolo,Sinvhal Ranjeeta,Armstrong April W.

Funder

AbbVie

Publisher

Elsevier BV

Subject

Dermatology

Reference76 articles.

1. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics;Menter;J Am Acad Dermatol,2019

2. Choosing first-line biologic treatment for moderate-to-severe psoriasis: what does the evidence say?;Amin;Am J Clin Dermatol,2018

3. Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis;Haugh;Drug Des Devel Ther,2018

4. The prevalence of herpes zoster and pityriasis rosea in patients with psoriasis: a preliminary study;Javor;J Eur Acad Dermatol Venereol,2016

5. German psoriasis registry PsoBest: objectives, methodology and baseline data;Augustin;J Dtsch Dermatol Ges,2014

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Etanercept in Paediatric Patients with Plaque-Type Psoriasis: Real-World Evidence;Journal of Clinical Medicine;2024-08-17

2. Geographic trends in psoriasis injectable biologic prescriptions by dermatologists among Medicare beneficiaries;Journal of the American Academy of Dermatology;2024-08

3. Real‐world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study;The Journal of Dermatology;2024-07-19

4. Targeted therapy for immune mediated skin diseases. What should a dermatologist know?;Anais Brasileiros de Dermatologia;2024-07

5. Biologics for Psoriasis;Dermatologic Clinics;2024-07